Biological Implant Tracking and Veteran Safety Act of 2015

Bill: 114-s-2334
Sponsor: Sen. Cassidy, Bill [R-LA]
Introduced: 2015-11-30 in the Senate
Policy area: Armed Forces and National Security
Subjects: Business records
Cell biology and embryology
Congressional oversight
Department of Veterans Affairs
Drug safety, medical device, and laboratory regulation
Government ethics and transparency, public corruption
Health information and medical records
Health technology, devices, supplies
Licensing and registrations
Organ and tissue donation and transplantation
Product safety and quality
Public contracts and procurement
Veterans' medical care

Summary:
action_date: 2015-11-30
text: 

Biological Implant Tracking and Veteran Safety Act of 2015

 
 This bill directs the Department of Veterans Affairs (VA) to: 
 
 
adopt the unique device identification system developed for medical devices by the Food and Drug Administration (FDA), or implement a comparable standard identification system, for identifying biological implants intended for use in VA medical facilities; 
 
permit a vendor to use any of the accredited entities identified by the FDA as an issuing agency; 
 
implement a compatible system for tracking implants from human donor or animal source to implantation; and 
 
implement inventory controls compatible with such tracking system so that patients who have received a biological implant in a VA medical facility subject to FDA recall can be appropriately notified. 
 
 
 The bill also prescribes requirements for vendors from which the VA may procure biological implants of human origin, and for vendors from which the VA may procure biological implants of non-human origin. Such a vendor must:
 
 
use the standard identification system adopted or implemented by VA under this Act;
 
be registered as required by FDA procedures;
 
 consent to periodic VA inspections and audits regarding records and product handling; 
 
 agree to cooperate with all biological implant recalls conducted on the vendor's own initiative, on the initiative of the original product manufacturer used by the vendor, or by FDA request or statutory order;
 
 agree to notify the VA within 60 days of any adverse event report it provides to the FDA, or of any FDA warning letter issued to the vendor; and 
 
agree to retain all records associated with the procurement of a biological implant by the VA for at least 10 years. 

 
 The VA shall: (1) procure such implants under General Services Administration Federal Supply Schedules if they are available under such Schedules, (2) accommodate reasonable vendor requests to undertake specified outreach efforts to educate VA medical professionals about the use and efficacy of implants, and (3) procure biological implants that are unavailable under such Schedules using competitive procedures in accordance with the Federal Acquisition Regulation.
 
 Any VA procurement employee responsible for a biological implant procurement transaction with intent to avoid, or with reckless disregard of, the requirements of this Act shall be ineligible to hold a certificate of appointment as a contracting officer or to serve as the representative of an ordering officer, contracting officer, or purchase card holder.
 
 Certain biological implants may be temporarily procured by the VA without relabeling under the standard identification system.


Legislative actions:
action_date: 2015-11-30
text: Read twice and referred to the Committee on Veterans' Affairs.
action_date: 2015-11-30
text: Introduced in Senate